JNBA Financial Advisors’s TG Therapeutics TGTX Stock Holding History

JNBA Financial Advisors’s Portfolio TGTX Stock Details TGTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$27.5K	Hold	500	–	–	﹤0.01%	401
2026 Q1	$16.6K	Hold	500	–	–	﹤0.01%	435
2025 Q4	$14.9K	Hold	500	–	–	﹤0.01%	449
2025 Q3	$18.1K	Hold	500	–	–	﹤0.01%	414
2025 Q2	$18K	Hold	500	–	–	﹤0.01%	407
2025 Q1	$19.7K	Hold	500	–	–	﹤0.01%	384
2024 Q4	$15.1K	Hold	500	–	–	﹤0.01%	415
2024 Q3	$11.7K	Buy	500 +200	+67%	+$4.37K	﹤0.01%	446
2024 Q2	$5.34K	Buy	+300	New	+$4.79K	﹤0.01%	523

Other funds holding TGTX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $15.4B AUM 30.35% 1-Year Est. Return

JNBA Financial Advisors's TGTX Position: Q2 2026 in Review

JNBA Financial Advisors held its TG Therapeutics (TGTX) position steady in Q2 2026 at 500 shares worth $27.5K. The position accounts for ﹤0.01% of the portfolio, ranked #401.

JNBA Financial Advisors first reported a position in TGTX in Q2 2024 and has held it in 9 quarters since. 431 funds tracked by Wall St. Rank hold TGTX as of Q2 2026.

JNBA Financial Advisors held 500 shares of TG Therapeutics worth $27.5K as of Q2 2026.
JNBA Financial Advisors left its TG Therapeutics share count unchanged in Q2 2026.
TG Therapeutics made up ﹤0.01% of JNBA Financial Advisors's portfolio in Q2 2026, its #401 holding.
JNBA Financial Advisors first reported a position in TG Therapeutics in Q2 2024 and has held it in 9 quarters since.
431 funds tracked by Wall St. Rank held TG Therapeutics as of Q2 2026.

Based on JNBA Financial Advisors's 13F filing for Q2 2026, filed 23 Jul 2026.